Devices › Device types
FDA product code LDF · class 2 · Cardiovascular
Electrode, pacemaker, temporary: medical device reports filed with FDA
2,032 reports carry this product code, 1992–2026; 9 brands with a page.
- 2,032
- reports with this product code
- 0% of all MAUDE reports
- 156
- reports, 12 months to August 2026
- 158 in the 12 months before
- 74%
- classified as malfunction
- 62.3% across all reports
- 3.2%
- classified as death, as reported
- 0.9% across all reports
Product code LDF is FDA's classification for "Electrode, pacemaker, temporary" (cardiovascular panel), a class 2 device. 2,032 medical device reports carry this product code, 0% of the MAUDE database, from July 1992 to August 2026.
156 reports arrived in the 12 months to August 2026, close to the 158 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (74%), injury (21.8%) and death (3.2%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Swan-Ganz Bipolar Pacing Catheter For SVC Insertion | 277 | 14 | 0% | 92.9% |
| Swan-Ganz Bipolar Pacing Catheter For Femoral Insertion | 164 | 2 | 0.4% | 97.9% |
| Patient Cable | 33 | 96 | 0% | 89.5% |
| Medtronic | 19 | 17 | 4.4% | 23.5% |
| Transvenous | 4 | 0 | 0.2% | 27.6% |
| Ethicon | 2 | 164 | 2.3% | 54.2% |
| Swan-Ganz catheter | 2 | 89 | 5.6% | 78.3% |
| Tempo | 1 | 155 | 0.7% | 58.3% |
| Zoll | 1 | 0 | 14% | 36.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Edwards Lifesciences Pr | 500 | 24.6% |
| Edwards Lifesciences | 76 | 3.7% |
| C R Bard Covington -1018233 | 70 | 3.4% |
| Medtronic Heart Valves Division | 50 | 2.5% |
| St Jude Medical | 37 | 1.8% |
| Oscor | 25 | 1.2% |
| Biosense Webster | 23 | 1.1% |
| Medtronic Heart Valves | 19 | 0.9% |
| Zoll Medical | 8 | 0.4% |
| Biosense Webster Juarez | 7 | 0.3% |
| Medtronic Heart Valve Division | 5 | 0.2% |
| B Braun Surgical | 3 | 0.1% |
| Bard | 3 | 0.1% |
| Medtronic | 3 | 0.1% |
| Physio-Control | 3 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Pacing problem | 652 | 32.1% |
| Breakthe device broke | 194 | 9.5% |
| Inflation problem | 112 | 5.5% |
| No pacing | 94 | 4.6% |
| Material separation | 67 | 3.3% |
| Fracturea broken bone | 54 | 2.7% |
| Material integrity problema problem with the device material | 39 | 1.9% |
| Insufficient device problem information | 32 | 1.6% |
| Replace | 32 | 1.6% |
| Failure to capture | 31 | 1.5% |
| Detachment of device component | 27 | 1.3% |
| Detachment of device or device componentpart of the device came off | 24 | 1.2% |
| Failure to sense | 24 | 1.2% |
| Fluid/blood leak | 24 | 1.2% |
| Material rupture | 24 | 1.2% |
| Explanted | 21 | 1% |
| Disconnection | 20 | 1% |
| Patient device interaction problem | 20 | 1% |
| Difficult to removethe device was hard to remove | 19 | 0.9% |
| Connection problema connection problem | 17 | 0.8% |
Questions about electrode, pacemaker, temporary reports
What is product code LDF?
FDA's classification code for "Electrode, pacemaker, temporary", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,032 reports through August 2026, 156 of them in the latest 12 months.
Which brands appear most often?
Swan-Ganz Bipolar Pacing Catheter For SVC Insertion (277), Swan-Ganz Bipolar Pacing Catheter For Femoral Insertion (164), Patient Cable (33), Medtronic (19) and Transvenous (4). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.